Cargando…

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection

The aim of this study was to define the therapeutic range for ribavirin (RBV) in transplant recipients with chronic hepatitis E virus (HEV) infection. In this retrospective multicentre cohort study, data of adult transplant recipients with chronic HEV infection, who had been treated with RBV monothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulder, Midas B., de Man, Robert A., Kamar, Nassim, Durmaz, Gűlcan, de Bruijne, Joep, Vanwolleghem, Thomas, Izopet, Jacques, Gandia, Peggy, van der Eijk, Annemiek A., van Gelder, Teun, Hesselink, Dennis A., de Winter, Brenda C.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983011/ https://www.ncbi.nlm.nih.gov/pubmed/33135238 http://dx.doi.org/10.1111/jvh.13432

Ejemplares similares

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin
por: Lhomme, Sebastien, et al.
Publicado: (2019)

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose
por: Berger, Florine A., et al.
Publicado: (2019)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose
por: Andrews, Louise M., et al.
Publicado: (2017)

Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography–tandem mass spectrometry
por: Bahmany, Soma, et al.
Publicado: (2018)

Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients
por: Francke, Marith I., et al.
Publicado: (2020)

Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series
por: Simoons, Mirjam, et al.
Publicado: (2023)

Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement
por: Andrews, Louise M., et al.
Publicado: (2019)

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
por: Tavitian, Suzanne, et al.
Publicado: (2015)

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation
por: van der Zwan, Marieke, et al.
Publicado: (2017)

Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections
por: Lhomme, Sébastien, et al.
Publicado: (2020)

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
por: Kamar, Nassim, et al.
Publicado: (2022)

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
por: de Winter, Brenda C. M., et al.
Publicado: (2009)

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response
por: van Wezel, E M, et al.
Publicado: (2019)

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
por: Francke, Marith I., et al.
Publicado: (2021)

Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France
por: Lhomme, Sebastien, et al.
Publicado: (2017)

Hepatitis E Virus: How It Escapes Host Innate Immunity
por: Lhomme, Sébastien, et al.
Publicado: (2020)

Hepatitis E Virus Shows More Genomic Alterations in Cell Culture than In Vivo
por: Sari, Gulce, et al.
Publicado: (2019)

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation
por: Andrews, Louise M., et al.
Publicado: (2017)

High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2022)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

Hepatitis E Pathogenesis
por: Lhomme, Sébastien, et al.
Publicado: (2016)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
por: Faguer, Stanislas, et al.
Publicado: (2022)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients
por: Protin, Caroline, et al.
Publicado: (2019)

Treatment of Chronic Hepatitis C Virus Infection in Dialysis Patients: An Update
por: Weclawiak, Hugo, et al.
Publicado: (2010)

Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
por: Kamar, Nassim, et al.
Publicado: (2016)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

Bioproduction of ribavirin by green microbial biotransformation
por: Rivero, Cintia W., et al.
Publicado: (2015)

Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2021)

Rabbit Hepatitis E Virus Infections in Humans, France
por: Abravanel, Florence, et al.
Publicado: (2017)

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021)

A new method to calculate intra‐patient variability in tacrolimus concentrations
por: van Gelder, Teun
Publicado: (2021)

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
por: Feld, Jordan J., et al.
Publicado: (2018)

Treatment for chronic hepatitis E virus infection: A systematic review and meta‐analysis
por: Gorris, Myrte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c9gelple41l7ud03kuhss9lrnu